The oncogenic effect of BRAFV600E in thyroid cells was shown to be mediated in part by TGF-β [37], and NOX4 is upregulated in thyroid cancer cells under the control of the BRAFV600E-TGF-β axis [17]. The gene discussed is NOX4; the disease is thyroid cancer.